Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Top Cited Papers
Open Access
- 28 May 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (22), 5412-5417
- https://doi.org/10.1182/blood-2008-12-194241
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell proliferative disorder associated with a life-long risk of progression tKeywords
This publication has 21 references indexed in Scilit:
- Pathogenesis and progression of monoclonal gammopathy of undetermined significanceLeukemia, 2008
- Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseasesBritish Journal of Haematology, 2007
- Monoclonal Gammopathy of Undetermined Significance: Predictors of Malignant Transformation and Recognition of an Evolving Type Characterized by a Progressive Increase in M Protein SizeMayo Clinic Proceedings, 2007
- Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosisBlood, 2006
- Methods for etiologic and early marker investigations in the PLCO trialMutation Research, 2005
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- Cyclin D dysregulation: an early and unifying pathogenic event in multiple myelomaBlood, 2005
- Advances in biology of multiple myeloma: clinical applicationsBlood, 2004
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002